CTRI/2019/01/017221招募中未知
Evaluation of safety and efficacy of fix dose combination of rosuvastatin, aspirin and clopidoGrel in patients with risk of acute cOronary syndrome: A prospective, observationaL, multicenter stuDy - GOLD
Aprica Healthcare Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1.Adult patients of either sex of 30 to 85 years of age (inclusive both) with evidence of coronary artery disease and/or Post PCI, or having risk of coronary artery disease as determined by clinical judgment of clinician
- •2.Patients receiving treatment of fixed dose combination of Rosuvastatin, Aspirin and clopidogrel
- •3.Patient willing to provide written informed consent document
排除标准
- •1.Patients receiving any other lipid lowering agent than study drug i.e. rosuvastatin
- •2.Patients receiving any other antiplatelet agent than aspirin and clopidogrel
研究者
相似试验
招募中
4 期
A Clinical Study to Evaluate the Safety and Efficacy of fixed dose combination of L-Ornithine-L-Aspartate 150 mg, Pancreatin IP 100mg enteric coated tablets as supportive and maintenance therapy in hepatitisCTRI/2022/06/043453Win Medicare Pvt Ltd
已完成
4 期
A Clinical Study to observe the effects of combination of Telmisartan and Amelodipine in patients with Uncontrolled Hypertension alone,Or with Type II Diabetes MellitusCTRI/2011/12/002189Glenmark Pharmaceuticals Ltd1,000
已完成
4 期
A clinical trial to study the effects of two drugs Olmesartan and metoprolol in patients with high blood pressure and heart diseaseCTRI/2010/091/001438Glenmark Pharmaceuticals Limited1,000
已完成
3 期
Safety and Efficacy Study of Fixed Dose Combination of Three Antidiabetic Drugs in Comparison to Two Antidiabetic Drugs in Patients with Type 2 DiabetesCTRI/2016/11/007439Sun Pharma Laboratories Limited301
已完成
3 期
A clinical trial to study the efficacy and safety of combination drugs of chlorthalidone, metoprolol and telmisartan in treatment of high blood pressure with stable coronary artery disease.CTRI/2016/11/007491Sun Pharma Laboratories Limited254